A new study examined whether urinary biomarkers could predict future kidney complications in individuals with lupus nephritis ...
March is National Kidney Month, a time to shine a light on the thousands of individuals whose lives are deeply affected by ...
Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that its abstract detailing clinical results ongoing Phase 1/2 trial ...
InvestigateTV+ shares a young mother’s struggle with the debilitating effects of lupus. Plus, we take an in-depth look at what could become a breakthrough treatment.
Nipocalimab, an FcRn blocker, receives FDA Fast Track status for SLE treatment after demonstrating significant improvements in disease activity.
Johnson & Johnson has won U.S. Food and Drug Administration fast-track designation for its investigational nipocalimab drug in adults with systemic lupus erythematosus, a chronic autoimmune disease.
Shontia Matlock shares her experience managing lupus and rheumatoid arthritis. Discover how she navigates treatment, faces emotional challenges, and advocates for herself.
Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...
Acute kidney injury (AKI) in patients with lupus nephritis is tied with rapid disease worsening and potential progression to chronic kidney disease and kidney failure.
Patients with RA or SLE who adhere to antimalarial therapy have a lower risk for hospital admission and fewer days of hospital stay than their nonadherent peers.
Scientists may have pinpointed a primary cause of lupus, a chronic autoimmune disease. Researchers from Northwestern Medicine in Chicago and Brigham and Women’s Hospital in Boston claim they have ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Maureen McMahon, ...